International Stem Cell CORP (ISCO)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Product sales | 2.447 | 2.129 | 2.179 | |
| Selling and marketing | 0.286 | 0.273 | 0.292 | |
| Research and development | 0.162 | 0.187 | 0.187 | |
| General and administrative | 0.905 | 0.892 | 0.816 | |
| Cost of sales | 0.927 | 0.992 | 0.974 | |
| Total operating expenses | 2.28 | 2.344 | 2.269 | |
| Income (loss) from operations | 0.167 | -0.215 | -0.09 | |
| Interest expense | 0.002 | 0.003 | 0.035 | |
| Interest expense - related party | 0.036 | 0.038 | - | |
| Total other expense, net | -0.038 | -0.041 | -0.035 | |
| Net income (loss) | 0.129 | -0.256 | -0.125 | |
| Undistributed earnings allocated to participating securities | 0.062 | - | - | |
| Net income (loss) attributable to common stockholders | 0.067 | -0.256 | -0.125 | |
| Earnings per share, basic, total | 0.01 | -0.03 | -0.02 | |
| Earnings per share, diluted, total | 0.01 | -0.03 | -0.02 | |
| Weighted average number of shares outstanding, basic, total | 8,004,389 | 8,004,389 | 8,004,389 | |
| Weighted average number of shares outstanding, diluted | 8,004,389 | 8,004,389 | 8,004,389 | |